drugset
drugset / Trial / NCT05974046

Single Dose Study of [14C]-IDV184001AN ([14C]-IDV184001) in Healthy Adult Male Participants

NCT05974046 ↗

Phase 1 Completed 7 enrolled Indivior Inc.
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this open label study is to characterise the absorption, metabolism, excretion, and mass balance of \[14C\]-IDV184001AN (\[14C\]-IDV184001) in healthy adult male participants.

Timeline

Start
2023-07-10
Primary completion
2023-07-21
Completion
2023-07-21

Drugs

EvaluationDrugModalityDoseRoute
Subject IDV184001AN Unknown 200 mg Oral

Indications

substance-related disorder